Pharmacokinetic and pharmacodynamic evaluations of oral moxifloxacin for Enterococcus faecalis endocarditis
Abstract
OBJECTIVES
Enterococcus faecalis is a challenging cause of endocarditis and often occurs in elderly, frail patients. The aim of this study was to evaluate the use of moxifloxacin for treating E. faecalis endocarditis by determining the probability of target attainment (PTA) and to investigate potential synergistic effects of moxifloxacin in combination therapy.
METHODS
Population pharmacokinetic modelling was performed using moxifloxacin data from patients in the Partial Oral Endocarditis Treatment (POET) trial who were infected with E. faecalis, staphylococci, or streptococci. The PTA was estimated from model-based simulations across a range of MICs and dosing regimens. Synergy testing of moxifloxacin in combination with amoxicillin or linezolid was conducted using checkerboard assays and time-kill assays with E. faecalis isolates.
RESULTS
Seventy-seven patients were included. Standard dosing (400 mg every day) achieved PTA >90% for MIC values ≤0.125 mg/L. At an MIC of 0.25 mg/L, PTA was 80.8% (90% CI: 73.4-87.5%) and increased to >90% with simulated doses of 600-800 mg every day. At an MIC of 0.5 mg/L, no regimen reached PTA >90%. Among 23 tested isolates, moxifloxacin MICs were 0.125 mg/L (3 of 23, 13%), 0.25 mg/L (17 of 23, 73.9%), and 0.5 mg/L (3 of 23, 13%). Checkerboard assays showed no synergy or antagonism with amoxicillin or linezolid. However, fractional inhibitory concentration indices were ≤1 in 18 isolates (18 of 23, 78.3%) for amoxicillin. Time-kill assays…
Read the paper
Related studies
- Structural and topological analysis of thiosemicarbazone-based metal complexes: computational and experimental study of bacterial biofilm inhibition and antioxidant activity
- Toward better cures for Mycobacterium abscessus lung disease
- Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing
- Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3‐Triazoles: A Computational Docking Techniques
- Upregulation of pmrA, pmrB, pmrC, phoQ, phoP, and arnT genes contributing to resistance to colistin in superbug Klebsiella pneumoniae isolates from human clinical samples in Tehran, Iran
- Whole-genome sequencing of clinical isolates of Citrobacter Europaeus in China carrying blaOXA−48 and blaNDM−1
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.